Chemical and Pharmaceutical Bulletin p. 28 - 36 (1999)
Update date:2022-08-04
Topics:
Suzuki, Tomoo
Oka, Mitsuru
Maeda, Kouji
Furusawa, Kenichi
Uesaka, Hiroshi
Kataoka, Tadashi
In order to develop drugs effective against Alzheimer's disease, we synthesized a series of aniline derivatives having a characteristic cyclic amine, 1-azabicyclo[3.3.0]octane ring, and evaluated their binding affinity for the central muscarinic cholinergic receptor. Among these compounds which showed high affinity to the M1 receptor, N-[2-(1-Azabicyclo[3.3.0]octan-5- yl)ethyl]-2-nitroaniline (9f fumarate, SK-946) showed the highest affinity. The ability of this compound to improve cognitive function was assessed using the passive avoidance test in scopolamine-induced dementia mice. Some anilines with a 1-azabicyclo[3.3.1]nonane ring were also synthesized by the ring expansion of the 1-azabicyclo[3.3.0]octane ring, and showed a high affinity for the central muscarinic cholinergic receptor.
View Morewebsite:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2，No. 489 Zhengli Road，200433
Hubei Honch Pharmaceutical Co.,Ltd
Contact:86-713-7222018
Address:Li Shizhen Pharmaceutical Industry park, Qichun County, Hubei Province,China
Chengdu Cogon Bio-tech Co., Ltd.
Contact:86-28-85171192
Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Weifang Dongxing Chitosan Factory
website:http://dxchitosan.lookchem.com/
Contact:13475651157
Address:Weifang city ,shandong province
Contact:+86-15850770348
Address:51 OF XIANGFANGCUN ROAD, Nanjing 210002, China
Doi:10.1016/0957-4166(95)00162-I
(1995)Doi:10.1021/ja00118a026
(1995)Doi:10.1016/0040-4039(95)00744-W
(1995)Doi:10.1021/acs.joc.0c01514
(2020)Doi:10.3762/bjoc.13.69
(2017)Doi:10.1021/ja00271a074
(1986)
